Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ANTARES PHARMA (NQ: ATRS)
4.060 USD  +0.080 (+2.01%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about ANTARES PHARMA
 
< Previous 1 2 3 4 5 6 Next >
Antares Pharma Announces Receipt of Sales-Based Milestone Payment from TEVA
May 04, 2010
from Business Wire News Releases
ANTARES PHARMA and UMAN PHARMA Enter Collaboration for VIBEX™ MTX
April 27, 2010
from Business Wire News Releases
Antares Pharma Reports Fourth Quarter and Year End 2009 Financial and Operating Results
March 23, 2010
Record Fiscal Year Revenue Read More
from Business Wire News Releases
Antares Pharma to Host Fourth Quarter and Full Year 2009 Earnings Call
March 15, 2010
from Business Wire News Releases
Antares Pharma to Present at the 22nd Annual ROTH OC Growth Stock Conference
March 11, 2010
from Business Wire News Releases
Antares Pharma to Present at the Cowen and Company 30th Annual Health Care Conference
March 04, 2010
from Business Wire News Releases
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol™ for the Treatment of Overactive Bladder
March 02, 2010
-- On Track for New Drug Application Filing in 2010 -- Read More
from Business Wire News Releases
Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.
February 03, 2010
from GlobeNewswire News Releases
ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES’ Patient-Friendly Injector for Growth Hormone Deficiency in Children
February 02, 2010
from Business Wire News Releases
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
January 20, 2010
from Business Wire News Releases
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
January 11, 2010
First Transdermal Contraceptive ATD™ Gel Contains Nestorone® Read More
from Business Wire News Releases
Fundamental Analysis on RWT, FCN, THI, GRT, SLB and AIS brought to you by AnalystChoice.com
November 19, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). Read More
from Marketwired News Releases
Antares Pharma Enters into License and Asset Purchase Agreements with Ferring
November 11, 2009
from Business Wire News Releases
Antares Pharma Reports Third Quarter 2009 Financial and Operating Results
November 09, 2009
from Business Wire News Releases
Antares Pharma to Present at the Merriman Investor Summit 2009
November 03, 2009
from Business Wire News Releases
Antares Pharma to Host Third Quarter 2009 Earnings Call
November 02, 2009
from Business Wire News Releases
Antares Pharma to Present at the 20th Annual Oppenheimer Healthcare Conference
October 27, 2009
from Business Wire News Releases
RidgewaterEquity.com Free Fundamental Sector & Market Research on GET, JAG, GSX, RTK, MJN and AIS
October 20, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Ridgewater Equity (RWE). Read More
from Marketwired News Releases
Antares Pharma, Inc. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
September 03, 2009
from Business Wire News Releases
Antares Pharma Announces Launch of Tjet Needle-Free Injector System by Marketing Partner Teva
August 25, 2009
from Business Wire News Releases
Antares Pharma Regains NYSE Amex Listing Compliance
August 14, 2009
from Business Wire News Releases
Antares Pharma Reports Second Quarter 2009 Financial and Operating Results
August 13, 2009
from Business Wire News Releases
Antares Pharma Welcomes Eamonn P. Hobbs to Board of Directors
August 12, 2009
from Business Wire News Releases
Antares Pharma to Host Second Quarter 2009 Earnings Call
August 04, 2009
from Business Wire News Releases
CORRECTING and REPLACING Antares Pharma, Inc. to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference
August 03, 2009
from Business Wire News Releases
Antares Pharma Receives Payment from Teva for Commercial Development of Vibex™ Auto-Injector Product
July 30, 2009
from Business Wire News Releases
Antares Pharma Announces Closing of Securities Offering
July 29, 2009
from Business Wire News Releases
Antares Pharma, Inc. to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference
July 28, 2009
from Business Wire News Releases
A.I.S. Resources Limited Announces Non-Brokered Private Placement of Preferred Shares
July 08, 2009
from Marketwired
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
July 08, 2009
from Business Wire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here